Invesco
CORV

Invesco’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Invesco’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,518
Closed -$103K – 4119
2014
Q3 		$103K Buy
+11,518
New +$83.8K ﹤0.01% 3827

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIG
Fortress Investment Group New York $531M AUM 12.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco's CORV Position: Q4 2014 in Review

Invesco sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2014, closing a stake of 11,518 shares — an estimated $103K sold.

Invesco first reported a position in CORV in Q3 2014 and held it in 1 quarter. The position peaked at $103K in Q3 2014. 30 funds tracked by Wall St. Rank hold CORV as of Q4 2014.

  • Invesco reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2014 after selling out during the quarter.
  • Invesco sold 11,518 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2014, an estimated $103K.
  • Invesco first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2014 and held it in 1 quarter.
  • Invesco's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $103K in Q3 2014.
  • 30 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2014.

Based on Invesco's 13F filing for Q4 2014, filed 13 Feb 2015.